Lambert-Eaton Myasthenic Syndrome Unmasked by Administration of Aggravating Medications

Anphong Nguyen^1, , Chukwuemeka A. Umeh¹ and Jose Penaherrera¹

¹Department of Internal Medicine, Hemet Global Medical Center, California USA

Cite this paper

Anphong Nguyen, Chukwuemeka A. Umeh and Jose Penaherrera. Lambert-Eaton Myasthenic Syndrome Unmasked by Administration of Aggravating Medications. American Journal of Medical Case Reports. 2022; 10(8):194-196. doi: 10.12691/AJMCR-10-8-4

Abstract

We present a case of an elderly female patient presenting with symptoms strongly suggestive of Myasthenia Gravis (MG), but later serological workup was shown to be more consistent with Lambert Eaton Myasthenic Syndrome (LEMS). On presentation, the patient had both profound ptosis and generalized weakness of the upper and lower extremities that were suspected clinically to be due to MG. The case was further complicated by the administration of several medications, which were believed to have unmasked her disease. Diagnostic imaging to assess for thymoma and lung cancer was negative. Screening with the ice-pack test was positive; however, serology for MG was negative. This case illustrates the importance of keeping the differential of LEMS in view in every suspected MG case, even if there is a low suspicion of LEMS initially. In addition, it demonstrates the possibility that the "ice-pack test" can also be positive in LEMS, and MG-unmasking medications may also unmask LEMS, an association that has not been described in our literature review.

Keywords

format, microsoft word template, style, insert, template

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Nicolle MW. Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome. Continuum (Minneap Minn). 2016 Dec; 22 (6, Muscle and Neuromuscular Junction Disorders): 1978-2005.
[2]	Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995 Jun 1; 332(22): 1467-74.
[3]	Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008 Feb; 37(2): 141-9.
[4]	Werner P, Kiechl S, Löscher W, Poewe W, Willeit J. Distal myasthenia gravis frequency and clinical course in a large prospective series. Acta Neurol Scand. 2003 Sep; 108(3): 209-11.
[5]	Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. 2006 Jul; 16(7): 459-67.
[6]	Golnik KC, Pena R, Lee AG, Eggenberger ER. An ice test for the diagnosis of myasthenia gravis. Ophthalmology. 1999 Jul; 106(7): 1282-6.
[7]	Giannoccaro MP, Paolucci M, Zenesini C, Di Stasi V, Donadio V, Avoni P, Liguori R. Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis. Neurology. 2020 Sep 29; 95(13): e1800-e1806.
[8]	Choi Decroos E, Hobson-Webb LD, Juel VC, Massey JM, Sanders DB. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis? Muscle Nerve. 2014 Jan; 49(1): 30-4.
[9]	Oh SJ, Jeong D, Lee I, Alsharabati M. Repetitive nerve stimulation test in myasthenic crisis. Muscle Nerve. 2019 May; 59(5): 544-548.
[10]	A Ahmed, Z Simmons. Drugs Which May Exacerbate or Induce Myasthenia Gravis: A Clinician's Guide. The Internet Journal of Neurology. 2008 Volume 10 Number 2.